Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Total Debt: 2014-2016

Historic Total Debt for KalVista Pharmaceuticals (KALV) over the last 1 years, with Mar 2016 value amounting to $4.7 million.

  • KalVista Pharmaceuticals' Total Debt rose 3.84% to $4.7 million in Q1 2016 from the same period last year, while for Mar 2016 it was $4.7 million, marking a year-over-year increase of 3.84%. This contributed to the annual value of $127,000 for FY2016, which is N/A change from last year.
  • Per KalVista Pharmaceuticals' latest filing, its Total Debt stood at $4.7 million for Q1 2016, which was up 0.91% from $4.6 million recorded in Q4 2015.
  • In the past 5 years, KalVista Pharmaceuticals' Total Debt ranged from a high of $4.7 million in Q1 2016 and a low of $4.4 million during Q4 2014.
  • For the 3-year period, KalVista Pharmaceuticals' Total Debt averaged around $4.5 million, with its median value being $4.5 million (2015).
  • Data for KalVista Pharmaceuticals' Total Debt shows a peak YoY grew of 3.92% (in 2015) over the last 5 years.
  • Quarterly analysis of 3 years shows KalVista Pharmaceuticals' Total Debt stood at $4.4 million in 2014, then rose by 3.92% to $4.6 million in 2015, then grew by 3.84% to $4.7 million in 2016.
  • Its Total Debt was $4.7 million in Q1 2016, compared to $4.6 million in Q4 2015 and $4.6 million in Q3 2015.